Thomas T. Pham

Array ( [id] => 16125907 [patent_doc_number] => 10696694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-30 [patent_title] => Lanthanide complexes for crystallising biological macromolecules and determining the crystallographic structure thereof [patent_app_type] => utility [patent_app_number] => 16/061691 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 30171 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15361033 [patent_doc_number] => 20200016281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => TREATMENT OF PMSA EXPRESSING CANCERS [patent_app_type] => utility [patent_app_number] => 16/470104 [patent_app_country] => US [patent_app_date] => 2016-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3796 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15666383 [patent_doc_number] => 10597409 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-24 [patent_title] => Water-soluble triazapyridinophane-based complexing agents and corresponding fluorescent lanthanide complexes [patent_app_type] => utility [patent_app_number] => 16/060291 [patent_app_country] => US [patent_app_date] => 2016-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 13418 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12246302 [patent_doc_number] => 09919064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Compositions, methods, and systems for the synthesis and use of imaging agents' [patent_app_type] => utility [patent_app_number] => 15/359675 [patent_app_country] => US [patent_app_date] => 2016-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 115161 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11935228 [patent_doc_number] => 20170239377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-24 [patent_title] => 'MOLECULAR PROBES FOR MULTIMODALITY IMAGING AND TRACKING OF STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/350389 [patent_app_country] => US [patent_app_date] => 2016-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15193 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15350389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11618385 [patent_doc_number] => 20170128572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-11 [patent_title] => 'LONG-LIVED GADOLINIUM BASED TUMOR TARGETED IMAGING AND THERAPY AGENTS' [patent_app_type] => utility [patent_app_number] => 15/343580 [patent_app_country] => US [patent_app_date] => 2016-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 9296 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13982665 [patent_doc_number] => 20190060490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => PAMAM DENDRIMER BASED CEST IMAGING AGENTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/771786 [patent_app_country] => US [patent_app_date] => 2016-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13425201 [patent_doc_number] => 20180264143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => SALICYLIC ACID-BASED POLYMERIC CEST CONTRAST AGENTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/764316 [patent_app_country] => US [patent_app_date] => 2016-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15913 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12259464 [patent_doc_number] => 20180078660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-22 [patent_title] => 'CRYSTALLINE CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING, KIT AND COMPOSITION COMPRISING IT AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 15/271368 [patent_app_country] => US [patent_app_date] => 2016-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 10630 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15271368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16141303 [patent_doc_number] => 10703712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Farnesoid X receptor agonists and uses thereof [patent_app_type] => utility [patent_app_number] => 15/758707 [patent_app_country] => US [patent_app_date] => 2016-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40409 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 660 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12165373 [patent_doc_number] => 09884132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-06 [patent_title] => 'Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof' [patent_app_type] => utility [patent_app_number] => 15/187274 [patent_app_country] => US [patent_app_date] => 2016-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10504 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15187274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15422507 [patent_doc_number] => 10544167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-28 [patent_title] => Compounds as stimuli-responsive probes, methods and applications thereof [patent_app_type] => utility [patent_app_number] => 15/755283 [patent_app_country] => US [patent_app_date] => 2016-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 11958 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12425094 [patent_doc_number] => 09974869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-22 [patent_title] => Chelated PSMA inhibitors [patent_app_type] => utility [patent_app_number] => 15/246483 [patent_app_country] => US [patent_app_date] => 2016-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12599 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15246483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15130153 [patent_doc_number] => 10478513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Nitroxide containing amyloid binding agents for imaging and therapeutic uses [patent_app_type] => utility [patent_app_number] => 15/748556 [patent_app_country] => US [patent_app_date] => 2016-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 13707 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12043385 [patent_doc_number] => 09820969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-21 [patent_title] => 'Methods for treating and diagnosing blinding eye diseases' [patent_app_type] => utility [patent_app_number] => 15/236861 [patent_app_country] => US [patent_app_date] => 2016-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 50 [patent_no_of_words] => 32518 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15236861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11471203 [patent_doc_number] => 20170057986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'MAGNETIC RESONANCE IMAGING CONTRAST AGENT CAPABLE OF DETECTING HYDROGEN PEROXIDE AND REDUCING REACTIVE OXYGEN SPECIES' [patent_app_type] => utility [patent_app_number] => 15/230030 [patent_app_country] => US [patent_app_date] => 2016-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 24166 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15230030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11421233 [patent_doc_number] => 20170029377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'SITE-SPECIFIC DYNAMIC NUCLEAR POLARIZATION NMR AGENTS' [patent_app_type] => utility [patent_app_number] => 15/222428 [patent_app_country] => US [patent_app_date] => 2016-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23806 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15222428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13339721 [patent_doc_number] => 20180221400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => COMPOSITIONS AND METHODS RELATING TO GALECTIN DETECTION [patent_app_type] => utility [patent_app_number] => 15/747649 [patent_app_country] => US [patent_app_date] => 2016-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25821 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13675535 [patent_doc_number] => 20160376501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => OXYGEN SENSORS [patent_app_type] => utility [patent_app_number] => 15/208027 [patent_app_country] => US [patent_app_date] => 2016-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10364 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15208027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11401686 [patent_doc_number] => 20170022224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'HBED-Bisphosphonates, Radiometal Conjugates and Their Use as Theranostic Agents' [patent_app_type] => utility [patent_app_number] => 15/203602 [patent_app_country] => US [patent_app_date] => 2016-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18741 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15203602 [rel_patent_id] =>[rel_patent_doc_number] =>)